NCT02621112View on ClinicalTrials.gov

HBV Vaccine in Renal Failure Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

March 31, 2019

Conditions
Renal Failure
Interventions
BIOLOGICAL

Intradermal HBVv with imiquimod

Intradermal hepatitis B vaccine with imiquimod pretreatment

BIOLOGICAL

Intradermal HBVv with aqueous cream

Intradermal hepatitis B vaccine with aqueous cream pretreatment

BIOLOGICAL

Intramuscular HBVv with aqueous cream

Intramuscular hepatitis B vaccine with aqueous cream pretreatment

Trial Locations (1)

Unknown

University of Hong Kong, Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT02621112 - HBV Vaccine in Renal Failure Patients | Biotech Hunter | Biotech Hunter